||Improving Probability of Success in Drug Development: Opportunities in Early Phase Trials
Event Date: June 13, 2017 11:00 am ET | 15:00 (GMT/UTC)
Groundbreaking innovations in basic science are "pushing" clinical development to be agile and creative, with the intent of translating scientific discoveries into medical benefit more rapidly and convincingly, while reducing failure rates in Late Phase development. Clinical development is shifting from the traditional static Phase I-II-III structure to a more fluid continuum that leverages tools like adaptive designs and drives continuous drug development from Early Phases to Late Phases. Regulators support this shift, as long as sponsors present it persuasively. What does this mean for the future of Early Phase clinical trials?
Topics for discussion:
Who should attend:
Professionals from pharmaceutical and biotechnology companies involved in early phase trials.
This webinar is intended for pharmaceutical and biotechnology professionals. A valid business email address is required to attend. This webinar is complimentary.